Neuromuscular Block in Laryngeal Mask Airway(LMA) Insertion

Effect of Neuromuscular Blockade on the Insertion of ProSeal™ Laryngeal Mask Airway and Postoperative Pharyngolaryngeal Discomfort

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01035021

Enrollment

160

Registered

2009-12-18

Start date

2009-06-30

Completion date

2010-04-30

Last updated

2013-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Disease, General Anesthesia

Brief summary

The aim of this study is to evaluate the success rate, insertion time and complication depending on the use of neuromuscular blocking agent when inserting the laryngeal mask airway (LMA).

Interventions

DRUGuse of rocuronium when the LMA is inserted

Anesthesia is induced with a propofol and remifentanil in both groups, however rocuronium 0.06 mg/kg is injected only in group R. Insertion of LMA is performed by the standard technique according to the manufacturer's instruction. In group N, rocuronium is administered for the operation.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* 18-70 year * american society of anesthesiologist status 1-2 * elective general anesthesia

Exclusion criteria

* known or predicted difficult airway * recent sore throat * mouth opening less than 2.5 cm * at risk of aspiration

Design outcomes

Primary

Measure	Time frame
success rate and insertion time	when laryngeal mask airway is inserted

Secondary

Measure	Time frame
complication after the remove of LMA - bleeding, sore throat	1 hour after the LMA is removed

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026